EZZ Life Science Holdings Limited

EZZ

AU0000130569

Food Processing

Market Closed - Australian S.E. Other stock markets 04:10:27 11/02/26 pm AEDT			5-day change	1st Jan Change
1.645 ^AUD	-2.66%		+2.17%	+16.67%

22/01	EZZ Life Science Holdings Appoints Chair	MT
22/01	Ezz Life Science Holdings appoints Gary Liu as non-executive chair	RE

Ezz Life Science Launches In U.S. Market And Receives FDA Registrations

Published on 06/19/2025 at 08:26 am AEST

Reuters

Latest news about EZZ Life Science Holdings Limited

22/01	EZZ Life Science Holdings Appoints Chair	MT
22/01	Ezz Life Science Holdings appoints Gary Liu as non-executive chair	RE
16/01	Ezz Life Science Holdings Limited Announces Appointment of Directors, Effective 16 January 2026	CI
02/12	EZZ Life Science Holdings Names Chief Strategy Officer, Shares Fall Over 5%	MT
02/12	EZZ Life Science Holdings Limited Announces Appointment Of Glenn Cross As Chief Strategy Officer	CI
28/11	Ezz Life Science says Mark Quinn will assume the role of interim chair	RE
28/11	EZZ Life Science Holdings Limited Announces Board Changes	CI
05/11	EZZ Life Science Holdings Declares Final Dividend	MT
05/11	Ezz Life Science Holdings to pay fully franked final dividend A$0.020 per share	RE
05/11	Ezz Life Science Holdings Limited Declares Dividend for the Twelve Months Ended June 30, 2025, Payable on December 23, 2025	CI
22/09/25	EZZ Life Science Holdings Limited(ASX:EZZ) dropped from S&P/ASX Emerging Companies Index	CI
29/08/25	EZZ Life Science Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2025	CI
19/06/25	EZZ Life Science Launches in the US; Shares Up 10%	MT
19/06/25	Ezz Life Science Launches In U.S. Market And Receives FDA Registrations	RE
10/06/25	EZZ Life Science Holdings Signs Distribution Agreement with ROFA for Thailand, Vietnam, Singapore; Shares Jump 9%	MT
10/06/25	EZZ Life Science Signs Multi-Year Distribution Agreement With Rofa Enterprises	RE
06/05/25	EZZ Life Science Holdings Declares Interim Dividend	MT
06/05/25	Ezz Life Science Determines Fully Franked Interim Dividend Of A$0.020 Per Share	RE
06/05/25	EZZ Life Science Holdings Limited Announces Fully Franked Ordinary Fully Paid Dividend for the Six Months Ended December 31, 2024, Payable on June 17, 2025	CI
24/03/25	EZZ Life Science Holdings Limited(ASX:EZZ) added to S&P/ASX Emerging Companies Index	CI
11/03/25	EZZ Signs US Manufacturing Deal for Nutritional Supplements; Shares Fall 6%	MT
11/03/25	EZZ Life Science Announces Manufacturing Agreement With GLSP Inc.	RE
26/02/25	EZZ Life Science Holdings Limited Provides Sales Guidance for the Fiscal Second Half of 2025	CI
26/02/25	EZZ Life Science Holdings Limited, H1 2025 Earnings Call, Feb 26, 2025
26/02/25	EZZ Life Science Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2024	CI

Chart EZZ Life Science Holdings Limited

Duration

Period

EZZ: Dynamic Chart

EZZ Life Science Holdings Limited is an Australian genomic life science company. The Company has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), children's health, and weight management. The Company's segments include Brought in Lines and Company Owned products. Its portfolio includes EZZ and EAORON. The EZZ-branded product range encompasses a broad selection of health and wellbeing products, catering to individuals across all age groups and owned by the Company. The EAORON-branded products comprise a range of facial care items, and the Company serves as the exclusive distributor in Australia and New Zealand for selected channels. The EZZ-branded products include EZZ Hair Growth Spray Duo, EZZ Multi Vitamins Milk Powder for Children (for children ages three plus), EZZ KidzSure Formulated Nutrition Powder (for children ages three plus) and EZZ VitalSure Formulated Nutrition Powder (for adults).

Employees

Sector

Food Processing

Calendar

02/03 - Q2 2026 Earnings Release (Projected)

More about the company